IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Aetna Inc. (“Aetna” or the “Company”) (NYSE: AET) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares between August 15, 2016 and January 20, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.
If you purchased shares of Aetna during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at firstname.lastname@example.org.
The Complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: Aetna and its senior executives attempted to sway Aetna's engagement in the Public Exchanges for positive treatment from regulators in regards to the Humana acquisition; that the Company threatened to rescind its participation in public health insurance exchanges if the Department of Justice ("DOJ") attempted to block the merger; that Aetna withdraw from some public health insurance exchanges, as per its threat of leaving the marketplace once the DOJ filed suit to improve its litigation; that Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and that as a result, Defendants' statements regarding Aetna's business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at email@example.com.
This press release may constitute Attorney Advertising in some jurisdictions.